2019 Tumor Marker Testing Market Competitive Landscape: Strategic Assessments of Leading Suppliers
This new 795-page report from contains 61 tables, and provides a comprehensive analysis of the POC infectious disease testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC infectious disease testing market.
Rationale
The growing economic pressures on hospitals, coupled with advances in diagnostic Technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.
Market Segmentation Analysis
- Review of five POC market segments, including their dynamics, trends, structure,
size, growth and major suppliers.
- Five-year test volume and reagent sales forecasts for major infectious disease tests
by market segment:
- Physician Offices/Group Practices
- Emergency Rooms
- Ambulatory Care Centers
- Surgery Centers
- Birth Centers
Sales and Market Share Analysis
- Market shares of major infectious disease diagnostic reagent and instrument suppliers.
Current and Emerging Products
- Analysis of infectious disease diagnostic tests performed in POC testing locations.
- Review of leading infectious disease testing analyzers, both currently marketed and
those in development, including their operating characteristics, features and selling prices.
Technology Review
- Emerging Technologies and their applications for POC testing.
- Comprehensive listings of companies developing or marketing coagulation
testing Technologies and products, by assay.
Competitive Assessments
- Assessments of major suppliers and emerging market entrants,
including their sales, product portfolios, marketing tactics, joint ventures,
and new products in R&D.
Strategic Recommendations
- Specific opportunities for new infectious disease testing instruments and reagent systems with potentially significant market appeal during the next five years.
- Design criteria for POC testing products.
- Alternative business expansion strategies.
- Potential market entry barriers and risks.
Methodology
This report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and proprietary data files.
Copyright VENTURE PLANNING GROUP
This material is confidential for use by our clients only
and may not be reprinted or reproduced.
- Abbott
- AdnaGen/Alere
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics
- bioMerieux
- Bio-Rad
- CellSearch
- Cepheid
- Correlogic Systems/Vermillion
- Decode Genetics
- Diadexus
- Diagnocure
- Diasorin
- Eiken Chemical
- Elitech Group
- Epigenomics
- Enterix
- Enzo Biochem
- Exact Sciences
- Fujirebio
- Guided Therapeutics
- Hologic/Gen-Probe
- Kreatech/Leica
- Kyowa Medex
- Mackay Life Sciences
- Myriad Genetics
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- Polartechnics
- Polymedco
- PreMD
- Qiagen
- Quest Diagnostics
- Radient Pharmaceuticals
- Roche
- Scienion
- Sequenom
- Siemens Healthcare
- Takara Bio
- Targeted Diagnostics & Therapeutics
- Thermo Fisher
- Tosoh
- Veridex
- Wako Pure Chemicals
- Wallac/PE
- Zila/Alere
2020 Germany Microbiology Lab and POC Market for 100 Tests: Supplier Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers, 2019-2023
This presents a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key German market trends; reviews
View Report2020 France Microbiology Lab and POC Market for 100 Tests: Supplier Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers, 2019-2023
This presents a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key French market trends; reviews
View Report2024 Competing in the Global Cancer Diagnostics Market: Supplier Shares, Segment Forecasts for Major Tumor Markers, Latest Trends, Growth Opportunities
This new comprehensive seven-country study identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends in the U.S., five major European
View Report2020 Immunodiagnostics Market: US, Europe, Japan--Spot Fast-Growing Market Segments--Supplier Shares and Segment Forecasts for over 100 Therapeutic Drug Monitoring, Endocrine Function, Tumor Markers, Special Chemistry, Immunoproteins, and Drugs of Abuse Tests
This comprehensive seven-country report contains 1,115 pages and 450 tables. The report explores future trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; provides
View ReportFill The Form For Sample Request